Papers

Peer-reviewed literature with structured metadata.

Trials

Interventional and observational studies by status and phase.

Topics

Key themes across evidence, policy, and outcomes.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across policy and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

News

Announcements, funding, and regulatory movement.

Research recaps

Weekly evidence summaries with key takeaways.

Map of research

Landscape views of compounds, trials, and outcomes.

Clinical research

Clinical pipeline tracking by indication and sponsor.

Podcast

Conversations with investigators and policy leaders.

Newsletter

Updates on trials, funding, policy, and new papers.

Guides

Practical explainers on methodology and safety.

Pricing
Compound Profile

Midalozam

Explore the clinical and pharmacological profile for Midalozam, including current research trials and known mechanisms of action.

Pharmacology & Mechanism of Midalozam

Detailed pharmacological information is currently being assembled by our research team.

Quick Facts

  • Highest PhasePhase II
  • Key IndicationsDepressive Disorders, Anxiety Disorders

Connected Research

Recent clinical trials and academic literature investigating Midalozam.

Recent Clinical Trials

View all trials →
Completed

The use of simultaneous EEG and fMRI to monitor the effects of ketamine and midazolam on brain activity in healthy adult males

Not yet recruitingPhase II

Pilot study on the effects of ketamine on mood and eating disorder cognitions in enduring anorexia nervosa

Not yet recruitingPhase II

Pilot study of ketamine in phobic participants using virtual reality stimuli

Not yet recruitingPhase II

Replication study of ketamine in phobic participants using virtual reality stimuli

Not yet recruitingPhase II

Active-controlled trial of a Ketamine Assisted Group Mindfulness intervention for Alcohol Use Disorder

CompletedPhase II

Intra-operative sedation with S-Ketamine to improve depression in patients with mental depression.

Research you can trust, with privacy and clarity built in.

Company

  • About
  • Contact
  • Newsletter
  • Access Program

Product

  • Feedback
  • Roadmap
  • Changelog

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.